AI powered platform Opportunity to upsell LiLii AI-powered Lab Platform to mid to large biopharma companies seeking integrated workflows for drug development, leveraging AI to streamline analytical operations and CMC knowledge management.

MSaaS expansion Leverage Mass Spec as a Service offering to integrate MS data into preclinical and early clinical programs at potential client sites, targeting startups and mid-sized biotechs aiming to accelerate IND timelines.

Integrated ecosystem Highlight the fully integrated LiLii ecosystem as a differentiator for biotech firms transitioning to digital transformation, presenting a compelling case to supply chain, QA, and analytical teams with a unified platform.

Speed to IND Position curated analytical test packages and rapid design optimization as accelerants for drug candidates, aligning with sponsors who want faster IND filings and reduced development risk.

Strategic partnerships Target collaborations with biopharma incumbents and CROs seeking to modernize operations; emphasize milestone-driven biotech startup heritage and customer-centric service model to win long-term contracts.